腹腔镜辅助下远端胃癌D2根治术治疗进展期胃癌的效果观察

目的寻找进展期胃癌的最佳胃癌D2根治术方案。方法：抽取2014年12月-2015年12月来我院接受治疗的70例进展期胃癌患者作为研究对象，将这些胃癌患者随机分配成2个小组，35例开腹远端胃癌D2根治术为对照组，35例腹腔镜远端胃癌D2根治术为观察组，分析2组的手术结果。结果：观察组的术后恢复时间、切口长度、手术出血情况等情况均优于对照组。对照组的并发症状发生率为28．57％，观察组为5．71％。观察组死亡率和存活率分别是0．29％和97．14％；对照组分别是14．29％和85．71％。2种手术方案的手术情况、存活率和死亡率、并发症状均有明显差异（P〈0．05）。结论：进展期胃癌的最佳手术方案为腹腔镜远端胃癌D2根治术，该方案安全、可靠，值得推崇。

Objective To search for the optimal D2 radical operation for advanced gastric cancer in advanced gastric cancer. Methods：Selected December 2014 and 2015 December to our hospital for treatment of 70 cases in gastric cancer patients as the research object, thegastric cancer patients were randomly assigned into two groups, the open distal gastric cancer D2 radical operation practice in 35 cases in thecontrol group treated by, laparoscopy assisted distal gastrectomy D2 radical operation practice in observation group of 35 cases, analysis of twogroups of surgical results. Results：The postoperative recovery time, incision length, bleeding in the observation group were better than those inthe control group after D2 radical resection of distal gastric cancer D2. The incidence of concurrent symptoms was 28.57% in the control groupafter D2 radical resection of the distal gastric cancer. The incidence of concurrent symptoms was 5.71% in the observation group afterlaparoscopic D2 radical gastrectomy. The mortality rate and survival rate of the observation group were 0.29% and 97.14%, respectively. Thedeath rate and survival rate of control group were 14.29% and 85.71%, respectively. There were significant differences in the operationconditions, survival rate and mortality rate, and the symptoms of the two surgical procedures （P 〈 0.05）. Conclusion：The optimal operation ofadvanced gastric cancer is safe and reliable, which is safe and reliable for laparoscopic distal gastric cancer D2.